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Objectives: The health benefits of high-intensity interval 
training in cardiac rehabilitation warrant further research. 
We compared the effectiveness of low-volume high-intensity 
interval training vs continuous aerobic exercise training in 
chronic heart failure.
Design/Settings: Unblinded, two arm parallel design with 
random assignment to exercise interventions in out-patient 
hospital rehabilitation gym.
Methods: Patients with signs of chronic heart failure and 
ejection fraction < 45%, (mean age: 59.1 years (standard de-
viation (SD) 8.6); 3 women) completed 6 months of exercise 
using continuous aerobic exercise training (n = 9) or high-
intensity interval training (n = 8). Cardiorespiratory fitness 
was determined during cycle ergometry using respiratory 
gas exchange analysis. Functional capacity was assessed via 
sit-to-stand and gait speed. Quality of life was assessed using 
the MOS Short-Form 36 and Minnesota living with heart 
failure questionnaires. Cardiac autonomic regulation was 
assessed using Heart Rate Variability.
Results: Analysis of Covariance revealed significant time ef-
fects but no group × time interactions for exercise and func-
tional capacity outcomes. Peak oxygen uptake (VO
2peak
) im-
proved by a mean of 14.9% (SD 16.3%) from baseline and by 
22% (SD 28.3) at ventilatory threshold in both groups. Sit-
to-stand (11.9 (SD 11%)) and gait speed (16.0 (SD 19%)) im-
proved similarly in both groups. No changes in quality of life 
or heart rate variability were noted. Training adaptations in 
high-intensity interval training were achieved despite a sig-
nificantly reduced time commitment and total work volume 
compared to continuous aerobic exercise training. 
Conclusion: Low-volume high-intensity interval training is a 
feasible and well tolerated training modality in cardiac reha-
bilitation settings, but is not more effective than continuous 
aerobic exercise training.
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INTRODUCTION
Current cardiac rehabilitation guidelines recommend between 
1,000–2,000 kcal or 150–180 min per week of moderate inten-
sity aerobic exercise (50–70% of peak oxygen uptake (VO2peak) 
for the delivery of health benefits (1, 2). Recent reports 
suggest that high-intensity interval training (HIT), eliciting 
an isocaloric work volume to continuous moderate intensity 
aerobic exercise (CAT), is feasible, safe, and probably more 
effective than CAT for the improvement of VO2peak in patients 
with cardio-metabolic disease (3, 4). In contrast, no systematic 
differences were identified between HIT and CAT for cardio-
metabolic outcomes of glucose and lipid metabolism, body 
weight or blood pressure (3, 4). The lack of an unequivocal 
evidence base for the benefits of HIT is such that it is not yet 
recommended in clinical practice.
Although no universal definition exists for HIT, it is 
understood to consist of short bouts of exercise exceeding 
90% of VO2peak interspersed by recovery periods of no or 
very low intensity activity (< 40% of VO2peak) (3–11). The 
utility of lower volume HIT applications in rehabilitation 
settings (< 200–250 kcal/session) (11), which may offer the 
potential to deliver benefits in a more time efficient manner 
(5–7, 11) remains unclear. Initial evaluations of low-volume 
HIT in the form of walking and cycling, 5 times a week for 
3 weeks, reported it to be safe and effective in delivering 
stronger exercise stimuli, in a group of hospitalised patients 
with chronic heart failure (CHF) (5–7). HIT elicited similar 
improvements in exercise capacity compared with CAT whilst 
also reducing exercise-related cardiac stress. However, the 
short duration and the high frequency delivery of this in-
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tervention limits its generalizability to more conventional 
out-patient rehabilitation.
physical activities (pA) performed at higher intensity are 
associated with higher levels of fitness and enhanced vagal 
autonomic control, when compared to moderate intensity pA 
levels in healthy individuals (12). High-intensity exercise has 
also been reported to improve cardiac autonomic regulation 
in patients with coronary artery disease (CAD), with changes 
in VO2peak positively correlating with changes in heart rate 
variability (HRV) (13). This may indicate the potential of this 
more intense exercise stimulus to effectively elicit greater 
improvements in exercise tolerance and cardiac autonomic 
control in patients with CHF, both of which have been reported 
to be powerful predictors of morbidity, mortality and health 
related quality of life (HRQoL) (14, 15). 
The benefits of exercise rehabilitation in the form of CAT in 
CHF are well established (15, 16). The current study therefore 
aimed to: (i) assess feasibility and tolerance of a low-volume 
HIT exercise protocol, delivered in an outpatient rehabilitation 
environment for people with CHF, and (ii) compare the rela-
tive effectiveness of low-volume HIT and conventional CAT 
interventions on indices of physical fitness, cardiac autonomic 
control, functional capacity and HRQoL. we hypothesised that, 
in comparison to CAT, HIT would elicit greater adaptations in 
the primary outcome variable (VO2peak), as well as in a range 
of secondary outcome variables.
METHODs
Design and randomisation
This was a pragmatic pilot feasibility study with a 2-arm parallel inter-
vention design. participants were randomly assigned (simple randomi-
sation), to receive either 24 weeks of CAT or HIT. participants were 
recruited on a continuous basis but completion of baseline assessments 
always preceded randomisation to an exercise group. All assessments 
were repeated after 12 and 24 weeks of training. Investigators were 
unblinded to group assignment. Fig. 1 provides details of patient flow 
through the study phases.
Setting and participants
Recruitment followed distribution of invitation letters and public 
advertisement. patients were considered for inclusion if they were 
adults over 18 years of age, had documented signs and symptoms of 
CHF with an ejection fraction (EF) < 45% and were in sinus rhythm. 
Exclusion criteria applied were diagnosis of diabetes, presence of 
pacemakers, major surgery or myocardial infarction within the 
previous 8 weeks. 
The study was performed in accordance with the Helsinki declaration 
and was approved by the North Staffordshire Local Scientific Merit and 
Ethical Committees and by the local Research & Development office. 
All participants were informed about the procedures of testing and 
training and any risks associated with these. All participants provided 
written informed consent. All authors meet the criteria for authorship.
Outcomes assessments
participants attended an outpatient rehabilitation gymnasium at North 
staffordshire University Hospital, Newcastle-under-Lyme, UK on two 
separate occasions lasting about 2 h each, at baseline and after 3 and 
6 months, to complete a range of assessments. The conduct of assess-
ments was standardised in order to minimise any potential effects of 
assessment-related fatigue, with functional capacity tests preceding 
incremental exercise tests, interspersed by sufficient resting periods 
during which participants completed all HRQoL questionnaires. 
Briefly, the assessments comprised: 
i) peak and sub-maximal exercise capacity (VO2peak and VO2 at venti-
latory threshold (VT) during ramp incremental cycle ergometry (15 
watts/min) using gas exchange measurements (K4b2 COsMED, 
Rome, Italy).VO2peak was defined as the highest value averaged 
over 30 s during the last stage of the incremental test and VT was 
determined using the V-slope method (2).
ii) Maximal short exercise capacity (MsEC) (maximum power output 
in watts) achieved during steep ramp cycle ergometry using 25 
watt increments every 10 s as described by Meyer et al. (6).
iii) Cardiac autonomic function using HRV measures obtained from 
a continuous 3 channel ECg portable Holter device worn for 
24 h (Tracker, Reynolds Medical Ltd, Hertfordshire, UK). The 
24-h ambulatory ECg recordings were replayed and analysed 
using commercially available software, (Pathfinder, Reynolds 
Medical Ltd) in order to eliminate any random non-sinus rhythm 
beats, noise and artifacts as described by Nolan et al. (14). Only 
recordings with > 80% of total recording time suitable for analysis 
were used. Time and Frequency domain measures of HRV were 
calculated (Triangular Index of a 24 h recording (TI24), standard 
deviation of all normal to normal intervals (sDNN), total power 
(Tot p24), low frequency (LF), high frequency (HF) expressed in 
Fig. 1. Patient flow diagram. CAT: continuous aerobic exercise training; HIT: 
high-intensity interval training; AF: atrial fibrillation; BP: blood pressure.
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normalised units and corresponding ratios reflecting balance of 
sympathetic and parasympathetic system activity during day and 
night). 
iv) Functional capacity/limitations were assessed via the sit-to-stand 
5 (sTs-5) and sit-to-stand 60 (sTs-60) tests as proxy indices of 
muscular power and endurance and the North staffordshire Royal 
Infirmary (NsRI) walk test (17), which consists of walking 50 m 
on flat ground, ascending and descending 22 steps and walking 
the same 50 m back, as fast as possible. 
v) Health related quality of life via the short-Form 36 (18) and the 
Minnesota Living with Heart Failure (MLwHF) questionnaires 
(19). The score for sF-36 can range from 0–100%, with a higher 
percentage indicating better total quality of life. The MLwHF 
score can range from 0–105 with higher scores indicating greater 
perception of severity and intrusiveness of heart failure related 
symptoms.
Exercise training interventions and management
patients attended the rehabilitation gym for supervised exercise train-
ing, 3 times a week for 24 weeks (72 planned sessions). patients in the 
CAT group cycled at an exercise intensity corresponding to 90% of 
their predetermined VT (corresponding to about 40–60% of VO2peak). 
Exercise stimulus progressed from 3 separate bouts of cycling of 
7–10 min in duration, to a single 40 min of continuous cycling bout 
by 5–6 months. 
patients in the HIT group, performed 2 × 15 min bouts of cycling, 
comprising very low intensity active cycling phases of 1 min at 25–40 
watts (equivalent to 20–30% of peak power output) followed by high 
intensity cycling for 30s at 50% of the maximum workload achieved 
during the MsEC test (equivalent to ~100% of peak power output 
during incremental exercise test), adhering to a work:recovery ratio 
of 1:2. Individualised patient exercise prescriptions were stored, for 
retrieval and implementation, on a programmable electronic cycle 
ergometer (Lode Corival, groningen, The Netherlands). 
For every training session, total cycling time, loaded cycling time 
(warm up, cool down and recovery periods excluded) and training 
workload (watts) were recorded, as well as Ratings of perceived 
Exertion (RpE), HR and bp responses. Training RpEs, HRs and bps 
were recorded at the mid-point and again at the end of the prescribed 
cycling sessions for each patient. Data included in the current analy-
sis reflect the mean of 3 sessions within a single week at baseline, 
and after 12 and 24 weeks of training. Energy expenditure (EE) 
during training sessions was estimated using the American College 
of sports Medicine’s metabolic calculation formula for leg cycling 
(VO2 = (10.8 × watts × body mass
–1) + 7). The estimated training VO2 
(L.min–1) was then converted into EE (kcal/min) by multiplying by 
5 x total number of cycling minutes. At 3 months, exercise prescriptions 
were adjusted accordingly to reflect new tolerance/exercise capacity 
levels. All exercise sessions were supervised by an appropriately 
trained exercise physiologist and cardiac rehabilitation staff. An ap-
propriately qualified clinical professional was always present during 
all incremental exercise tests. 
Statistical analysis
Data are presented as mean (sD) or median (min–max) where appro-
priate. sample size estimations were based on VO2peak as the primary 
outcome. For experimental power at 80% for an intended 0.5 effect size 
at a 0.05 significance level, 17 patients were needed to complete both 
arms of the study. Comparison of physical and clinical characteristics 
between patient groups at baseline, was performed using independent 
sample t-tests or non parametric equivalents. Mixed Model Factorial 
Analysis of Covariance  with baseline VO2peak as a covariate was used 
to assess main effects of time and the interaction between modality 
of training and time. where time effects were present, within group 
comparisons were performed using paired t-test if data were normally 
distributed or wilcoxon signed rank tests if otherwise. In addition, 
we calculated bias corrected Hedge’s standardised effect sizes (Es) 
in order to establish the extent of pre-post HIT intervention differ-
ence (effect) in comparison to CAT (viewed as the standard reference 
point). This was accomplished using an on-line spreadsheet resource 
(20). To allow comparisons between groups with no pre test equiva-
lence “adjusted” Ess were calculated by subtracting the pre-Es from 
the post-Es (21). All statistical analyses were performed using IbM 
statistics 19 for windows. 
REsULTs
Table I outlines the physical and clinical characteristics of 
the groups at baseline and indicates that no statistically sig-
nificant differences existed at study entry. Aetiology of CHF 
included: idiopathic dilated cardiomyopathy, CAD and viral 
cardiomyopathy. Medications were optimised across the obser-
vation period. From the CAT group, one patient had bisoprolol 
increased at 3 months and warfarin at 6 months and one patient 
was taken off statins and had ramipril increased at 3 months. 
In the HIT group, one patient had bisoprolol reduced, one was 
taken off ramipril, one had bisoprolol increased, with another 
started on diuretics at 3 months. At 6 months, one patient was 
started on statins and one on warfarin. seventeen patients 
completed all requirements of the study and remained in the 
final analysis. Patients who did not complete the study were 
physically weaker, reported worse social functioning and per-
ceived greater severity of CHF related symptoms at baseline 
(p < 0.05) (Table II).
Exercise training progression and tolerance
In comparison to HIT, patients in CAT, exercised for longer 
(p < 0.01, F = 35.2), at lower relative power outputs (p < 0.01, 
F = 20.5), but at similar levels of RpE and cardiovascular 
stress as indicated by calculated Rate pressure products 
(Rpp = (sbp × HR)/1000) (Table III). Total EE per session 







Male/female, n 13/4 14/2
Age, years, mean (sD) 59.7 (10.8) 59.8 (7.4)
bMI, kg.m2 –1 mean (sD) 29.5 (4.7) 28.9 (4.7)
NyHA, median (min–max) 2.0 (1–3) 2.0 (1–3)
EF, %, mean (sD) 35.2 (6.4) 41.7 (10.3)
VO2peak, ml
.kg–1.min–1, mean (sD) 15.5 (15.9) 14.6 (4.8)
sbp rest, mmHg–1, mean (sD) 125 (15) 114 (14)
Dbp rest, mmHg–1, mean (sD) 73 (11) 71 (10)
Diuretics, n 11 9
ACE inhibitors, n 13 10
b-blockers, n 10 11
statins, n 9 14
Ca channel blockers, n 1 2
Nitrates & nitroglycerin, n 6 6
VO2peak: peak oxygen uptake: CAT: continuous aerobic exercise training; 
HIT: high-intensity interval training; sD standard deviation; bMI: body 
mass index; NYHA: New York Heart Association Classification; EF: 
ejection fraction; sbp: systolic blood pressure; Dbp: diastolic blood 
pressure; ACE: angiotensin converting enzyme inhibitors.
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was significantly lower in the HIT group (p < 0.01, F = 31.7) 
and significantly increased over time (p < 0.01, F = 108.9) 
(Table III). 
During the observation period there was one episode of 
syncope during exercise (HIT) and one episode of what turned 
out to be an anxiety/panic attack (CAT). Two patients (CAT) 
although very keen to exercise, could not tolerate the exer-
cise prescription due to severe orthopaedic pain. On several 
occasions, patients attended the exercise gym, but were not 
subsequently allowed to exercise due to presence of cardiac 
rhythm abnormalities (2 patients developed atrial fibrillation 
and had to be referred to a specialist for re-evaluation), bp 
instability with symptoms, resting angina episodes, abnormal 
glucose levels. A number of patients were diagnosed with 
additional medical conditions during the training period. 
Table II. Physical and clinical characteristics of people who completed 






Male/female, n 14/3 13/3
Age, years, mean (sD) 59.1 (8.6) 60.5 (9.9)
bMI, kg.m2 –1, mean (sD) 29.2 (5.1) 29.2 (4.3)
NyHA, median (min–max) 2 (1–3) 3 (2–3)
EF, %, mean (sD) 38.4 (6.6) 37.7 (13.4)
VO2peak, ml
.kg–1.min–1, mean (sD) 16.5 (6.3) 13.3 (3.5)
sbp rest, mmHg–1, mean (sD) 115 (6) 124 (9)
Dbp rest, mmHg–1, mean (sD) 70 (11) 75 (11)
MLwHFq total, mean (sD) 24.6 (15.3) 50.2 (25.3)a
sF36-sF, mean (sD) 77.2 (24.7) 56.7 (32)a
sTs-5, s, mean (sD) 8 (2.9) 11 (4.7)a
sTs-60, mean (sD) 34.4 (12.9) 22.1 (13.4)a
peak power Output, w, mean (sD) 116.2 (34.9) 91.3 (30.4)a
aDifferent from completed p < 0.05.
MLwHFq: Minnesota Living with Heart Failure questionnaire; sF36-
sF: short-Form-36-social functioning component; sTs-5: 5 sit to 
stand transfers; sTs-60: sit-to-stand transfers in 60 s; VO2peak: peak 
oxygen uptake. 
Table III. Progression of exercise training prescription and associated training tolerance indices
CAT (n = 9)
HIT (n = 8) baseline 12 weeks 24 weeks
MsEC, watts, mean (sD) CAT 233.7 (47.5) 250 (44.3) 253.1 (36.4)
HIT 228.1 (60.4) 244.3 (54.2) 250 (61.2)
Total cycling time, min, mean (sD) CAT 26.8 (3.09) 39.5 (1.4)b 40 (0.0)a
HIT 30 (0.0) 31 (1.052)b 33.6 (1.21)a, b
EE for total cycling time, kcal, mean (sD) CAT 145.5 (39.3) 234.9 (43.8)b 260.8 (61.9)b
HIT 177.3 (39.3)a 196 (30)a, b 215.9 (33.4)b
Loaded cycling time, min, mean (sD) CAT 21.8 (3) 34.5 (1.4)b 36.2 (2.3)b
HIT 10 (0.0) 10.3 (0.5)a, b 11.4 (0.8)a, b
EE for loaded cycling time, kcal, mean (sD) CAT 123.5 (39.4) 212.9 (43.8)b 238.9 (62.3)b
HIT 85.9 (17.9)a 100.4 (24.9)a, b 114.4 (31.2)a, b
Training power Output, watts, mean (sD) CAT 52.2 (24.6) 62.5 (23)b 70 (27.3)b
HIT 107 (36) 126.6 (40.8)b 137.5 (45.3)b
Training power Output, watts.kg–1, mean (sD) CAT 0.69 (0.37) 0.88 (0.42) 1 (0.53)
HIT 1.26 (0.41)a, b 1.47 (0.48)a, b 1.58 (0.56)a, b
Training Rpp, bpm.mmHg–1, mean (sD) CAT 13.2 (2.6) 13.7 (3) 13.6 (3.3)
HIT 10.9 (2.5) 12 (3.2) 12.6 (3.1)
Training RpE, median (min-max) CAT 13 (11,15) 13 (12,15) 12 (11–15)
HIT 11 (10,12) 12 (11,12) 11 (11,12)
aDifferent from CAT p < 0.05; bdifferent from baseline p < 0.05. 
CAT: continuous aerobic exercise training; HIT: high-intensity interval training; MsEC: Maximum short Exercise Capacity; EE: Energy Expenditure; 
Rpp: Rate pressure product; RpE: bORg Rating of perceived Exertion; sD: standard deviation.
Fig. 2. group mean percentage changes in peak oxygen intake (VO2peak) (a) 
and VO2 at the ventilatory threshold (VT) (b), following 3 and 6 months 
of continuous aerobic exercise training (CAT) and high-intensity interval 
training (HIT) exercise rehabilitation.
a
b
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Although, some of these patients continued to attend the gym 
sporadically, maintenance of their exercise prescription could 
not be achieved so these patients were excluded from the final 
analysis. Patients included in the final analysis had completed 
at least 65 out of the planned 72 sessions.
Peak and submaximal exercise capacity
Table IV summarises selected indices of exercise responses 
at peak effort and at VT level. Over time, both groups signifi-
cantly improved peak exercise capacity and tolerance indices 
(Table IV, Fig. 2). CAT, but not HIT, significantly improved 
VO2 and power output at VT at 3 and 6 months compared to 
baseline. This was achieved at a similar level of cardiovascular 
stress as indicated by unchanged RPP (Table IV). No signifi-
cant interaction effects (group × time) were observed for any 
of the assessed outcomes, indicating that both interventions 
had similar impact on reported outcomes (Table IV and Fig. 
2). standardised Ess, adjusted for small sample sizes and for 
inequalities at baseline (Hedges bias corrected) indicate that 
the standardised difference in all assessment outcomes between 
the 2 groups, was always less than half a sD of the pooled sD. 
Cardiac autonomic function
Time and frequency domain HRV indices remained un-
changed at follow up assessment points. No significant time 
or group × time interactions were detected (Table V). 
Functional capacity and health related quality of life
Self reported NYHA symptom classification improved over 
time in the CAT group. Objectively-measured functional capac-
ity improved over time in both groups (Table VI). Indices of 
HRQoL remained unchanged at follow-up assessment points. 
None of the 8 subcomponents that make up the total score for 
the sF-36 questionnaire (physical function, role physical, gen-
Table IV. Exercise capacity indices following 3 and 6 months of exercise training. Continuous aerobic exercise training (CAT) is assumed to be the 
standard cardiac rehabilitation reference point for the purposes of effect sizes (ES) calculations
CAT (n = 9)














.min–1.kg–1 CAT 17.6 (7.1) 19.8 (7.8)a 18.9 (7.5) –0.36 (–1.32 to 0.6) –0.18 (–1.13 to 0.78) 0.18
HIT 15.3 (4.7) 17.3 (5.4)a 17.7 (4.9)a
power output, watts CAT 121.1 (31.2) 131.6 (37.5a 129.1 (32.3) –0.28 (–1.24 to 0.68) 0.12 (–0.83 to 1.07) 0.4
HIT 110.6 (40) 131.2 (32)a 133.7 (40.5)a
RER CAT 1.27 (0.13) 1.16 (0.07)a 1.25 (0.14) –1.14 (–2.16 to 0.11) –1.01 (–2.02 to 0.00) 0.13
HIT 1.13 (0.1) 1.12 (0.04) 1.13 (0.07)
peak Rpp, mmHg.beats–1 CAT 19.3 (6.5) 18.9 (6.6) 20.3 (5.2) –0.24 (–1.20 to 0.71) –0.13 (–1.09 to 0.82) 0.11
HIT 17.5 (7.5) 19.5 (6.8) 19.5 (6.3)
O2-pulse, ml
.beat–1 CAT 11.5 (3.3) 13.1 (4.02) 12.33 (3.44) –0.03 (–0.98 to 0.92) 0.22 (–0.73 to 1.18) 0.25
HIT 11.4 (2.8) 13.08 (3.21) 13.03 (2.40)
VO2-VT, ml
.min–1.kg–1 CAT 10.8 (3.1) 13.4 (4.2)a 13.5 (5.4)a –0.10 (–1.06 to 0.85) –0.35 (–1.31 to 0.61) 0.25
HIT 10.4 (4.3) 11.4 (2.8) 11.9 (2.6)
power output-VT , watts CAT 58.8 (21.4) 77.7 (17.5)a 76.3 (29.6)a 0.16 (–0.8 to 1.11) 0.06 (–0.89 to 1.01) 0.1
HIT 63.7 (36.6) 76.8 (24.3) 78.1 (24.9)
RER-VT CAT 1 (0.13) 0.91 (0.04)a 0.97 (0.09) –0.48 (–1.45 to 0.49) –0.05 (–1.01 to 0.90) 0.43
HIT 0.95 (0.04) 0.90 (0.05) 0.92 (1.3)
Rpp -VT, mmHg.beats–1 CAT 12.3 (3.9) 12.6 (3.7) 13.7 (4.7) 0.10 (–0.85 to 1.05) –0.26 (–1.22 to 0.70) 0.36
HIT 12.7 (3.7) 12 (2.8) 12.6 (3)
O2-pulse-VT, ml
.beat–1 CAT 9.03 (2.4) 11.3 (2.9)a 10.8 (3.2)a 0.34 (–0.78 to 1.13) 0.17 (–0.78 to 1.13) 0.17
HIT 9.9 (2.4) 10.9 (2.3) 11.3 (2.1)
aDifferent from baseline p < 0.05.
CAT: continuous aerobic exercise training; HIT: high-intensity interval training; RER: Respiratory Exchange Ratio; VT: ventilatory threshold; Rpp: 
Rate pressure product; VO2peak: peak oxygen intake: 95% CI: 95% confidence interval: SD: standard deviation.
Table V. Time and frequency domain heart rate variability (HRV) indices
Variables













Analysable recording (%) 97 (3.21) 96 (4.39) 95.7 (3.41) 96.85 (4.84) 96.42 (5.15) 95.1 (5.98)
TI24 35.3 (13.3) 35.2 (16.5) 38.14 (19.8) 31.5 (8.2) 28.1 (5.8) 33.4 (9)
sDNN, ms 131 (49) 128 (53) 130.7 (53.6) 112 (22) 101 (23) 117.4 (37.4)
Tot p24, ms2 2,188 (1,692) 2,247 (1,494) 2,811.87 (3,268) 3,342 (3,600) 2,669 (3,006) 1,757.14 (929.56)
LF/HF day 2.9 (1.8) 2.9 (2.2) 4.17 (3.7) 3.2 (3.1) 2.5 (2) 4.48 (3.07)
LF/HF night 3.3 (2.6) 2.4 (1.1) 2.06 (1.08) 3 (3.2) 2.8 (3.2) 3.10 (3.97)
CAT: continuous aerobic exercise training; HIT: high-intensity interval training; TI24: Triangular Index over a 24-h period; sDNN: standard deviation 
of all normal to normal beat intervals; Totp24: total power; LF/HF: low-frequency/high-frequency ratio.
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eral health, mental health, social functioning, vitality, bodily 
pain, role emotional) and for the MLwHF questionnaire (physi-
cal and emotional sub-scores) were significantly modified over 
time (data not shown). No significant group × time interactions 
were detected (Table VI). The calculated standardised Ess 
indicate that our interventions differed by less than half a sD 
of the pooled sD for all outcomes.
DIsCUssION
Our study contributes to the extremely limited knowledge 
base for the potential use of low-volume HIT in the clinical 
rehabilitation of patients with CHF. Our findings indicate that: 
i) low-volume HIT cycling is feasible and well tolerated by 
patients with CHF, ii) HIT elicited a broadly similar degree 
of improvement in physical function as CAT, despite a signifi-
cantly lower total training volume and exercise time commit-
ment, that were accompanied by similar levels of perceived 
effort and cardiovascular stress, iii) neither intervention was 
effective in favourably modifying cardiac autonomic function 
nor in favourably modifying HRQoL. 
based on adjustment for baseline inequalities Ess, we con-
sistently observed less than half a sD difference between the 
means of the 2 groups, for all exercise capacity indices, at the 
end of the follow up period. group mean VO2peak improved 
by 13% (sD 18.3%) and by 8.9% (sD 25.3%) from baseline, 
after 3 and 6 months in the CAT group. In comparison, the HIT 
group demonstrated a 15% (sD 15%) and 21.6% (sD 31.2%) 
improvement after 3 and 6 months, respectively. This level of 
improvement is in agreement with improvements ranging from 
8 to 16% for CAT and ~18% for HIT, reported in other studies 
comparing HIT vs CAT (22, 23). In contrast, wilsøff et al. (8) 
and Tjønna et al. (24) reported increases in VO2peak of 35–46%, 
corresponding to a gain of 4–6 ml/kg/min in VO2peak following 
HIT, even though their HIT protocols were very similar to ones 
used in other studies reporting much less marked improvements 
(22, 23, 25, 26). A meta-analysis of exercise rehabilitation trials 
in people with CHF (16) concluded that on average, a 2.16 ml/kg/
min increase in VO2peak is commonly observed. A meta-analysis 
on the efficacy of HIT applications in people with CV disease 
(3), reported that VO2peak was improved by at least 3.6 ml/kg/
min. Myers et al. (27) observed that an increase in VO2peak by an 
equivalent amount (1 MET) is associated with 9% reduction in 
mortality over a year in people with CV conditions. In the context 
of these clinically important evaluation criteria, although both 
our interventions met the minimum expected mean improve-
ment (Table IV) they fell short of reaching the 1 MET level of 
improvement. A closer examination of individual responses and 
group trends (Table IV, Fig 2a), seem to suggest that HIT was 
associated with a continuous fashion of improvement for VO2peak, 
whereas CAT improvements seemed to have levelled off after 
36 training sessions (Fig 2a). It is possible that the significantly 
higher relative workload prescribed during HIT training (see 
Table III), can improve tolerance of higher power outputs which 
in turn could sustain/enhance VO2peak gains. 
Conversely, if one considers the time pattern of adaptations 
at moderate levels of physiological demand (VT and functional 
capacity, Tables IV and VI), CAT seemed to produce faster 
adaptations, even though the overall adjusted Ess suggest no 
substantial difference between the groups at the end of the ob-
servation period. Improvements at this level reflect an enhanced 
cardiovascular/metabolic efficiency in sustaining higher levels 
of energy demands. It is possible that the greater total volume 
of exercise achieved by CAT at 3 months (Table III), was the 
main driver for the faster adaptations at VT level. Time effects 
of CAT on O2-pulse (Table IV), that may suggest underlying 
improvements in stroke volume and/or O2 extraction ability, 
could partially explain these adaptations, especially in the 
absence of any substantial changes in HR and sbp (Rpp-VT) 
(28). Our results partially disagree with two studies (8, 29), 
that have reported greater improvements in VO2 at VT in pa-
tients with CAD and CHF who followed HIT training (32% 
Table VI. Objective and self report functional capacity and quality of life following 3 and 6 months of exercise training
CAT (n = 9)







NyHA class CAT 2 (1–3) 2 (1–2)a 2 (1–2)a 0.00 (–0.95 to 0.95) 0.42 (–0.55 to 1.38) 0.42
HIT 2 (1–3) 2 (1–2) 2 (1–2)
sTs-60 CAT 37 (14.4) 41.1 (16.4)a 40.7 (15.1)a –0.40 (–1.37 to 0.56) –0.24 (–1.20 to 0.71) 0.16
HIT 31.5 (11) 35.7 (13.3) 37.3 (11)a
sTs-5, s CAT 7.5 (2.1) 6.3 (1.6)a 6.6 (2.1)a 0.39 (–0.57 to 1.35) 0.13 (–0.82 to 1.08) 0.26
HIT 8.7 (3.6) 7.8 (2.5) 6.9 (2.3)a
NsRI total, s CAT 83.9 (18.6) 73.8 (17.1)a 71.4 (16.1)a 0.51 (–0.45 to 1.48) 0.75 (–0.23 to 1.74) 0.24
HIT 101.4 (43) 90.5 (25.3) 87.8 (24.8)a
gait speed, m.s–1 CAT 1.33 (0.32) 1.53 (0.43)a 1.56 (0.38)a –0.42 (–1.38 to 0.54) –0.77 (–1.76 to 0.22) 0.35
HIT 1.18 (0.36) 1.24 (0.29) 1.28 (0.30)a
MLwHFq total CAT 22.8 (12.9) 24.6 (20.3) 37 (24) 0.23 (–0.73 to 1.19) –0.17 (–1.12 to 0.79) 0.40
HIT 26.6 (18.3) 29.1 (15.7) 33.3 (17.6)
sF36-total CAT 67 (20.2) 71.8 (19.1) 62.7 (24.8) –0.31 (–1.27 to 0.65) –0.28 (–1.24 to 0.68) 0.03
HIT 59.8 (24.1) 59.7 (18.9) 56.3 (17.1)
aDifferent from baseline p < 0.05. 
CAT: continuous aerobic exercise training; HIT: high-intensity interval training; NYHA: New York Heart Association classification; STS-60: Sit-to-
Stand transfers in 60 s; STS-5: time for 5 Sit-to-Stand transfers; NSRI: North Staffordshire Royal Infirmary; MLWHFQ: Minnesota Living with Heart 
Failure Questionnaire; SF36-total: Short-Form 36 Health Survey total score; 95% CI: 95% confidence interval.
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and 41%, respectively) compared to patients in CAT (9.5 and 
26.2% increases). The interventions in the aforementioned 
studies were designed to be isocaloric with an estimated (from 
information available in the literature) EE/week for the HIT 
prescription (walking at 80–90% VO2peak) of ~1,002 kcal vs 942 
kcal for the CAT (50–60% VO2peak) programme. In contrast, 
our training regimens were not designed to be isocaloric, so 
our HIT prescription, elicited a significantly lower volume of 
exercise compared to CAT (Table III). Our weekly cycling 
EE progressed from 436 kcal/week at baseline to 704.7 kcal/
week by 12 weeks for CAT vs 531 to 588 kcal/week for HIT, 
inducing statistically similar increases in VO2-VT (CAT: 23.9% 
vs HIT:16.8%) (Fig. 2). These observations may indicate that 
there is a critical threshold of total volume of work (EE) that 
needs to be achieved before training stimuli become optimally 
effective in modifying metabolic and CV efficiency at moderate 
levels of exercise. In all other studies that have used similar 
isocaloric HIT and CAT training protocols (8, 9, 13, 22–26), 
achievement of higher EE was perhaps easier, as the exercise 
prescriptions combined high (80–95% VO2peak or HR max) and 
moderate intensity (60–70% of HR max or VO2peak) longer ex-
ercise phases (2–4 min) of weight bearing physical activities. 
It may be unrealistic to expect this level of EE, during cycling 
in particular, in typical cardiac rehabilitation programmes. 
Nevertheless, our lower volume HIT protocol was not worse 
than CAT in eliciting favourable adaptations. 
To our knowledge, only one other study that has examined 
the effectiveness of a HIT protocol vs usual care in people 
with CHF, has reported functional capacity outcomes (9). 
Functional capacity outcomes are important, as they can 
represent outcomes more meaningful to patients and can ulti-
mately translate into enhanced physical independence and QoL. 
Nilsson et al. (9) reported that a high-intensity dance circuit 
programme significantly improved distance walked over 6 min, 
by 58 m. In our study, gait speed improved in both groups by 
about 18.3% (sD 14) in CAT and by 13.4% (sD 24) in HIT, 
despite the mode of training being cycling. we also observed 
significant improvements over time in both groups, for tasks 
primarily reflecting leg muscular power and fatigue tolerance 
(sTs-5: CAT: 11 (sD 10%) vs HIT: 18 (sD 8.6%) and sTs-
60: CAT:11 (sD 12%) vs HIT: 26 (sD 37.7%). Our results 
are encouraging as they indicate that whole body integrated 
physiological adaptations translated into similar levels of im-
provement in the ability to perform common activities of daily 
living. In contrast, our patients’ perception of overall QoL did 
not substantially change in any group (Table VI). surprisingly, 
the improvements noted in objectively measured functional 
capacity were not reflected in the relevant physical function 
sub-components of the questionnaires used (data not shown). 
In the study by Nilsson et al. (9), the significant improvement 
in walking capacity was accompanied by significant improve-
ments in the MLwHF score in the exercise group. However, 
the exercise group started from a significantly higher baseline 
value (30) compared to the usual care group (23) and thus at the 
end both groups had very similar scores. Recent meta-analyses 
have suggested that QoL changes in patients with CHF, do not 
always parallel changes in physical function outcomes follow-
ing exercise rehabilitation, with small or no changes reported 
for a variety of HRQoL measures (15, 16). Our patients had 
baseline scores similar to those reported elsewhere (9, 31, 
32) using the same assessment outcome and thus our data are 
within the expected range.
Reduced HRV is considered a significant prognostic indi-
cator of mortality in CHF (14). Aerobic exercise training of 
moderate intensity has been shown to have sympathoinhibitory 
effects in addition to pharmacotherapy (30, 32–38). Resistance 
based exercise training has also been reported to produce some 
favourable modification in indices of exercise performance 
but with no associated modulation of autonomic function (30, 
34). Our results indicate that none of our exercise stimuli were 
effective in altering cardiac autonomic regulation. Data from 
our patients indicate an increased level of sympathetic activa-
tion that persisted even at times during which a predominance 
of parasympathetic modulation would be expected (39) (see 
Table VI, LF/HF night vs LF/HF day). It is also worth not-
ing a declining trend in total p24, in the HIT group, which is 
an index of total amount of variability in the regulation of 
HR over a 24-h period (39). These observations may reflect 
worsening of underlying medical conditions and the general 
health status over time, as many patients experienced several 
health challenges that resulted in substantial pauses of the 
exercise training programme on occasions. It is also possible 
that the overall volume of work was not sufficient to provoke 
changes to, or override the medication effects on, these indices 
of cardiac autonomic regulation. Meyer et al. (5), whose train-
ing protocol we have reproduced here, observed no changes 
in resting epinephrine and norepinephrine levels following 
a 3 week training period in patients with CAD. On the other 
hand, Munk et al. (13) observed significant improvements in 
HRV indices in patients with CAD, following a 6 month high 
volume HIT training (> 900 kcal/week). Future studies should 
aim to evaluate different volumes of HIT training to establish 
a threshold of consistent effect on HRV outcomes in CHF.
Study limitations
One could argue that a greater number of participants were 
required to increase confidence in the observations made. Al-
though the low completion numbers were disappointing, they 
reflected the high comorbidity burden of these patients that 
ultimately precipitated withdrawal from the study or delayed 
progression and adherence to the exercise protocols. In cases 
of pauses > 2 weeks in the training plan, we compensated 
by offering more training sessions, so that every patient had 
accumulated at least 85% of planned sessions. These draw-
backs may of course have diluted the magnitude of potential 
improvements. Moreover, due to funding limitations, travel 
reimbursement and blinding of the investigators to the interven-
tions and assessments was not possible. Unblinded outcome 
assessment can potentially introduce bias in the reported 
data, although every effort was made to collect and analyse 
the data as objectively as possible. we feel however, that our 
investigative approach was acceptable, given that this was a 
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pragmatic feasibility study and these are common experiences 
and occurrences within such patient groups in real-life clinical 
rehabilitation settings. 
In conclusion, our study shows favourable training adapta-
tions in people with CHF following low-volume HIT training. 
Compared to CAT exercise and functional capacity adaptations 
were achieved against a background of significantly reduced 
training time and total volume of work, with similar levels 
of perceived exertion and haemodynamic stress. These are 
important observations that may allay some of the concerns 
regarding the use of HIT for people with pathophysiologically 
reduced exercise tolerance. Moreover, the potential value of our 
HIT approach may be in its utility for severely deconditioned 
and cachectic CHF patients where improvements in physical 
function are desired in the context of energy preservation and 
time efficiency. 
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